Medicare will only cover FDA-approved monoclonal antibodies that target amyloid to treat Alzheimer’s disease for beneficiaries enrolled in qualifying clinical trials.
News
Latest
The agency will accept comments until May 9 on ways to improve the Organ Procurement and Transplantation Network.
The customizable toolkit offers resources to help prevent central line-associated bloodstream infections and catheter-associated urinary tract infections.
The AHA’s American Organization for Nursing Leadership will present 2022 awards for diversity, leadership and achievement during its annual conference next week in San Antonio.
by Rick Pollack
For more than two full years – day in and day out – hospitals and health systems and their front-line caregivers have cared for patients, comforted families and protected communities during this unprecedented public health crisis.
As Congress prepares to adjourn for its April recess, AHA today emphasized to congressional leaders the need for immediate additional support for hospitals and health systems.
Health care providers who missed the deadline to report on period 1 Provider Relief Funds due to certain extenuating circumstances may request April 11-22 to submit a late report.
Certain emergency blanket waivers issued for nursing homes, skilled nursing facilities and other settings in response to the COVID-19 public health emergency will end in 30 or 60 days, depending on the waiver.
Congress in December prohibited implementing the model before January 2023.
The agency recommends health care facilities that still use fixed endcap duodenoscopes complete their transition to newer models that can lower infection risks.
The legal principles discussed also apply to individuals with other types of substance use disorders.
AHA’s national advisor for cybersecurity and risk speaks with leaders from University of Vermont Medical Center about the attack.
CMS plans to launch next week the online portal through which uninsured and self-pay patients may initiate the dispute resolution process.
The Centers for Medicare & Medicaid Services today released a memorandum and provider-specific guidance on complying with the interim final rule.
Medicare and Medicaid will cover a second Pfizer or Moderna COVID-19 booster at no cost to eligible enrollees.
President Biden yesterday directed the HHS secretary to coordinate the federal response.
HHS has stopped distributing the monoclonal antibody sotrovimab because the BA.2 omicron variant now predominates in every U.S. state and territory.
The Food and Drug Administration yesterday alerted health care providers to a recall and change in reprocessing methods for certain urological endoscopes made by Karl Storz.